Pakshaghata in Ayurveda: A Critical Narrative Review of Classical Descriptions, Clinical Correlates, and Contemporary Evidence for Stroke Rehabilitation
DOI:
https://doi.org/10.47070/ijapr.v14i10.4486Keywords:
Pakshaghata, Hemiplegia, Ayurveda, Stroke Rehabilitation, Panchakarma, Narrative ReviewAbstract
Pakshaghata is a classical Ayurvedic description of predominantly unilateral functional impairment that overlaps clinically with hemiplegia but cannot independently identify stroke subtype. Objective: To examine the classical descriptions, critically synthesize contemporary clinical research on Ayurveda-based stroke rehabilitation, and identify safety and research priorities. Methods: This critical narrative review drew on specified Ayurvedic textual loci, targeted searches of published clinical studies, accessible journal records and contemporary stroke guidelines through November 2026. An author-supplied teaching compendium informed verse identification but was not treated as primary clinical evidence. Results: A 2025 systematic review identified 30 heterogeneous clinical studies, with widespread risk-of-bias and reporting limitations. The multicenter RESTORE randomized trial enrolled 140 ischemic-stroke survivors and did not establish superiority of Ayurvedic rehabilitative treatment over conventional physiotherapy at three months (adjusted p=0.057). A 52-participant non-randomized comparison suggested short-term mobility differences with massage added to physiotherapy; selection bias prevents causal attribution. An 18-participant blinded pilot demonstrated feasibility of procedure-based comparative research, not definitive efficacy. Conclusion: Classical descriptions permit cautious clinical-phenotype comparisons but not claims of equivalent disease mechanisms. Current evidence is insufficient to establish an additional functional benefit or long-term safety of Ayurvedic interventions beyond guideline-based rehabilitation. Adequately powered adjunctive trials with standardized interventions, validated outcomes, independent assessment and rigorous adverse-event monitoring are needed.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 International Journal of Ayurveda and Pharma Research

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

